Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

What are Vaccines?

There are several diseases like Diphtheria, whooping cough (pertussis), measles, mumps, Yellow fever, small pox and German measles (rubella) that are unfamiliar to many these days.

Vaccine History

What is a Vaccine Breakthrough?

What are the Main Causes of Vaccine Hesitancy?

Investigating the Importance of Investing in Vaccine Manufacturing

Vaccine Schedule

Vaccine Effectiveness

Vaccination in Humanitarian Settings

Plant-Derived Vaccines

Vaccine Production

Vaccine Excipients

Vaccine Delivery

See more featured articles »

Vaccine Immunity

Hib Immunization

History of Vaccination

How are Vaccines Stored?

What are the Different Types of Vaccines?

What is a Subunit Vaccine?

What is an Inactivated Vaccine?

What is a Live-Attenuated Vaccine?

What is a Toxoid Vaccine?

What is an RNA Vaccine?

What is a DNA Vaccine?

What are Adenovirus-Based Vaccines?

What is a Non-Replicating Vaccine?

What is a VLP Vaccine?

What are Nanoparticle-Based Vaccines?

The Future of Vaccines

Insight into Personalized Vaccines

Could there be a Salmonella Vaccine?

Role of Computer Modeling in Vaccine Development

How Veterinary Vaccines Affect Human Health

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

What is the Importance of Vaccination Coverage?

The Big Catch-Up: How the COVID-19 pandemic impacted vaccination coverage

Transforming Vaccine Design: The Promise of Systems Biology

What is Immunobridging?

Immunization strategies: What lessons can we learn from successful campaigns?

The Essential Program on Immunization is 50: Milestones, achievements, and future directions

Latest Vaccine News and Research

What is the ‘immune self,’ and how can this concept benefit immunological research?

A perspective review discusses the concept of the 'immune self' and how adaptive immune responses are influenced by self-similarity. The study emphasizes advances and challenges in defining self-similarity and its impact on immunological research.

13 May 2024

Experimental gene therapy shows promise for treating herpes infections

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.

13 May 2024

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

Study shows clear benefit from COVID-19 vaccination for heart failure patients

Heart failure patients who are vaccinated against COVID-19 have an 82% greater likelihood of living longer than those who are not vaccinated, according to research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology.

13 May 2024

Leveraging AI to connect social media discourse with public health trends

"Sticks and stones may break my bones," the old adage goes. "But words will never hurt me."

13 May 2024

Breakthrough research offers promise for developing new immune therapies for cancer

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.

9 May 2024

Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodies

A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.

9 May 2024

Common drivers of high-performing public health programs revealed

The highest performing countries across public health outcomes share many drivers that contribute to their success.

9 May 2024

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.

9 May 2024

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.

9 May 2024

AVAnT1A study: Investigating early COVID-19 vaccination and type 1 diabetes risk in children

Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy.

8 May 2024

Study unveils crucial insights into how COVID-19 vaccines mitigate severe illness

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

8 May 2024

Tailored vaccine may hold the key to treating eczema in children

New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children.

8 May 2024

New Quartet nanocage vaccine shows promise against coronavirus variants

Researchers have developed a novel vaccination approach using Quartet nanocages that display receptor-binding domains (RBDs) from different sarbecoviruses, showing enhanced immune responses and potential protection against diverse coronavirus strains including SARS-CoV-2 and its variants.

8 May 2024

Mobile teams boost immunization rates in rural Sierra Leone

COVID-19 vaccination rates remain low in many African countries, often because providing access to vaccines is difficult in remote areas.

7 May 2024

50 years of lifesaving vaccinations: WHO's EPI saves 154 million lives

The World Health Organization’s Expanded Programme on Immunization (EPI) has prevented 154 million deaths since 1974, significantly reducing global infant mortality and contributing 10.2 billion years of healthy life due to vaccinations.

7 May 2024

New vaccine technology provides protection against broad range of coronaviruses in mice

Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don't even know about.

6 May 2024

Durable lymph-node expansion improves vaccine responses against tumors

Each one of us has around 600 lymph nodes (LNs) – small, bean-shaped organs that house various types of blood cells and filter lymph fluid – scattered throughout our bodies.

6 May 2024

Lessons learned: Strategies for future pandemic response based on mpox experience

Targeted support for marginalized communities, strong public messaging and a properly coordinated Government approach led by Ministers are amongst the recommendations contained in a new evidence-based article examining how the UK should respond to future pandemics.

6 May 2024

New influenza vaccine strategies aim to enhance protection with T-cell responses

A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.

6 May 2024